Curated Health Wellness News

NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.

RSS Feed for Health Wellness NewsJSON Feed

GLORIOUS Trial: Exenatide Infusion Does Not Significantly Reduce Complications in Heart Surgeries

November 17, 2024 — A large-scale clinical trial presented at the American Heart Association’s Scientific Sessions 2024 found that intravenous infusion of exenatide during heart surgeries involving bypass did not significantly reduce the risk of death, stroke or organ failure. The study challenges the previous belief that exenatide could offer significant benefits in reducing complications during and after cardiac surgery.

AI Program PanEcho Could Revolutionize Heart Image Interpretation

November 16, 2024 — Using artificial intelligence to interpret echocardiograms may lead to faster diagnosis and treatment of heart conditions, improving patient outcomes and potentially saving lives. PanEcho's ability to accurately assess all major findings from any set of echocardiography videos has the potential to streamline the diagnostic process and make medical care more accessible.

Feedback to Pharmacists Improves Heart Failure Patient Care

November 16, 2024 — Pharmacists receiving feedback and educational resources saw a significant increase in managing heart failure and adjusting heart failure medications, as revealed in a study presented at the American Heart Association’s Scientific Sessions 2024. The findings underscore the potential for real-time feedback to improve heart failure and chronic disease management.

Anti-Clotting Medications Not Effective for Younger Adults with AFib: Study

November 16, 2024 — Study reveals that prescribing anti-clotting medications to younger adults with AFib and no other risk factors for stroke does not reduce the risk of cognitive decline, stroke, or TIA. The findings challenge current treatment guidelines and may impact healthcare decisions for this patient population.

Intensive Blood Pressure Treatment Lowers Cardiovascular Risk in Type 2 Diabetes Patients

November 16, 2024 — An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes reduces the risk of heart attack, stroke, heart failure and death due to cardiovascular disease. The study's findings provide valuable insights for healthcare professionals and patients, potentially leading to a more intensive systolic blood pressure target for the prevention of major cardiovascular events in this at-risk population.

REM Holdings, Inc. Provides Update on Deltawave Product Launch

November 15, 2024 — REM Holdings, Inc. provides an update on the delayed launch of the Deltawave product, projecting its introduction by the end of January 2025. The news sheds light on the company's commitment to compliance and the potential impact of the new product on the market.

Acadia Healthcare Company Faces Securities Class Action Lawsuits

November 14, 2024 — Acadia Healthcare Company (NASDAQ: ACHC) faces securities class action lawsuits after allegations of false/misleading statements and harmful practices. Investors urged to submit losses. Impacting corporate accountability in healthcare.

Silexion Therapeutics Reports Q3 Financial Results and Business Update

November 14, 2024 — Silexion Therapeutics Corp. (NASDAQ: SLXN) reported its Q3 financial results and provided an update on recent business developments, including the completion of its business combination with Moringa Acquisition Corp. The company's progress with LODER™ and SIL-204 demonstrates its commitment to advancing RNA interference therapies for challenging cancers. The financial updates also provide valuable insight into Silexion's growth and strategic milestones.

American Heart Association and American Red Cross Release 2024 First Aid Guidelines

November 14, 2024 — The American Heart Association and the American Red Cross have released the “2024 Guidelines for First Aid,” providing critical updates to equip first aid responders with the latest evidence-based practices. These updates reflect the changing landscape of public health challenges and aim to equip trained professionals and the public with lifesaving skills that are more critical than ever.

Mountainside Treatment Center Joins Optum Network

November 14, 2024 — Mountainside Treatment Center is now in-network with Optum, expanding access to high-quality addiction treatment services. This partnership will allow more individuals and families to start healing from substance use disorders.

Documentary 'Stealth Syndromes' to Raise Awareness of Treatable Conditions

November 14, 2024 — The 'Stealth Syndromes' documentary aims to raise awareness about common but often overlooked chronic conditions, offering hope and support for individuals suffering from undiagnosed health issues. The global initiative connects patients with knowledgeable providers and pharmacies, bringing an end to needless suffering.